Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Absciabsci.comAbsci is building an AI-driven drug creation platform that integrates data generation, AI-driven de novo antibody design, and wet-lab validation to create differentiated biologics from scratch. It combines AI-enabled target discovery via reverse immunology with iterative six-week design cycles to optimize candidates and advance IND-enabling studies, including examples like ABS-201 targeting prolactin receptors for androgenetic alopecia. Absci partners with pharma, tech, and academic leaders to accelerate internal and partnered programs and deliver better biologics to patients faster.
Words AI uses
AI reaches for ai-driven · generative ai · proprietary when it describes Absci.
Sources
synbiointel.com shapes more of what AI says about Absci than any other source, at 20% of its citations.
absci.com · youtube.com · arxiv.org · biopharmatrend.com
The market map
Biopharma Research Platforms and Services →Where AI ranks Absci
Excerpts where Absci appeared in the AI's answer
Absci: A prominent publicly traded platform that tightly integrates generative AI with high-throughput wet-lab validation.
Absci : Combines generative AI with high-throughput wet-lab validation loops.
Excerpts where Absci appeared in the AI's answer
Absci: Merges drug discovery and biological manufacturing into a unified AI-driven platform.
Excerpts where Absci appeared in the AI's answer
Absci combines wet-lab data generation with generative AI foundation models
Excerpts where Absci appeared in the AI's answer
Absci: Uses AI to design and validate new therapeutic antibodies by combining generative AI with high-throughput wet-lab data.
Absci: An AI-driven drug discovery company that creates new biologics by integrating wet-lab data with AI design.
